INDAPAMIDE\PERINDOPRIL ERBUMINE: 294 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

294

Total FAERS Reports

26 (8.8%)

Deaths Reported

210

Hospitalizations

294

As Primary/Secondary Suspect

Life-Threatening

Disabilities

First Report: 20060717 · Latest Report: 20240810

What Are the Most Common INDAPAMIDE\PERINDOPRIL ERBUMINE Side Effects?

#1 Most Reported

Asthma

43 reports (14.6%)

#2 Most Reported

Drug intolerance

42 reports (14.3%)

#3 Most Reported

Eosinophilia

40 reports (13.6%)

Side Effect	Reports	% of Total	Deaths	Hosp.
Asthma	43	14.6%	0	36
Drug intolerance	42	14.3%	0	37
Dyspnoea	40	13.6%	1	36
Eosinophilia	40	13.6%	0	34
Obstructive airways disorder	37	12.6%	0	31
Drug ineffective	35	11.9%	0	33
Hyponatraemia	34	11.6%	0	31
Acute kidney injury	33	11.2%	5	25
Bronchitis	33	11.2%	0	32
Asthma-chronic obstructive pulmonary disease overlap syndrome	31	10.5%	0	31
Breath sounds abnormal	31	10.5%	0	31
Bronchial hyperreactivity	31	10.5%	0	31
Cardiac disorder	31	10.5%	0	31
Cardiomyopathy	31	10.5%	0	31
Ischaemic cardiomyopathy	31	10.5%	0	31
Pulmonary function test abnormal	31	10.5%	0	31
Hypotension	21	7.1%	3	21
Fall	20	6.8%	2	17
Asthenia	17	5.8%	2	13
Pancreatitis	16	5.4%	0	14

Gender: 44.1% female, 55.9% male. Average age: 67.3 years. Most reports from: CA. View detailed demographics →

Year	Reports	Deaths	Hosp.
2006	1	0	1
2013	4	0	4
2014	4	1	3
2015	17	2	15
2016	19	6	15
2017	36	2	26
2018	24	5	17
2019	27	2	19
2020	17	2	15
2021	10	1	9
2022	4	0	3
2023	3	1	2
2024	4	1	3

Indication	Reports
Hypertension	141
Product used for unknown indication	113

Official prescribing information from the FDA-approved drug label.